Eli Lilly (LLY) Stock Climbs After Mounjaro Sales Soar; Wegovy’s Heart Study
August 29, 2023
Eli Lilly (LLY) stock jumped following earnings which saw its diabetes drug Monjaro sales soar and news it could reduce heart risk.
Research Reports
Eli Lilly (LLY) Stock Soar on the Back of Two Potential Blockbuster Drugs
June 12, 2023
Eli Lilly (LLY) shares have been soaring as Mounjaro for weight loss and Donanemab for Alzeimer’s could fuel profits for years.
Drug Maker Eli Lilly (LLY) Caps the Price of Insulin to $35 a Month
March 7, 2023
Eli Lilly (LLY) capped the price of insulin it provides to Americans at $35 a month. But LLY’s weight loss drug should be the big news.
Eli Lilly (LLY) Might Have a Weight Loss Drug that Could Be a Blockbuster
December 1, 2022
Eli Lilly (LLY) continues to rise as it has developed what could become the next big weight loss drug, pending approval from the FDA.
Eli Lilly (LLY) Has Two New Drugs That Could Become Blockbusters
September 28, 2022
Eli Lilly (LLY) has two potential blockbuster drugs — for weight loss and Alzheimer’s — that could bring big profits down the road.
Earnings
LLY 2023 Q4
August 22, 2023
Eli Lilly (LLY) is expected to report qtrly profits (EPS) and revenues:
Profits Estimates: $2.97 vs. $1.98 = +50%
Revenue Est: +28%